Salient Capital Advisors’s Oracle ORCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-9,376
Closed -$470K 148
2017
Q2
$470K Sell
9,376
-23,125
-71% -$1.05M 0.01% 153
2017
Q1
$1.45M Buy
32,501
+3,083
+10% +$128K 0.03% 113
2016
Q4
$1.13M Buy
29,418
+2,954
+11% +$116K 0.02% 119
2016
Q3
$1.04M Sell
26,464
-81
-0.3% -$3.3K 0.02% 118
2016
Q2
$1.09M Buy
26,545
+3,363
+15% +$134K 0.02% 119
2016
Q1
$948K Buy
23,182
+6,581
+40% +$244K 0.03% 125
2015
Q4
$606K Buy
16,601
+7,901
+91% +$302K 0.02% 157
2015
Q3
$314K Sell
8,700
-222
-2% -$8.54K 0.01% 194
2015
Q2
$360K Buy
8,922
+400
+5% +$17.4K 0.01% 205
2015
Q1
$368K Buy
8,522
+222
+3% +$9.62K 0.01% 194
2014
Q4
$373K Sell
8,300
-604
-7% -$24.6K 0.01% 196
2014
Q3
$341K Sell
8,904
-469
-5% -$19K 0.01% 197
2014
Q2
$380K Buy
9,373
+173
+2% +$7.12K 0.01% 184
2014
Q1
$376K Hold
9,200
0.01% 184
2013
Q4
$352K Buy
9,200
+200
+2% +$6.88K 0.01% 172
2013
Q3
$299K Buy
9,000
+1,825
+25% +$59.2K 0.01% 142
2013
Q2
$220K Buy
+7,175
New +$238K 0.01% 148

Other funds holding ORCL

Salient Capital Advisors's ORCL Position: Q3 2017 in Review

Salient Capital Advisors sold out of Oracle (ORCL) in Q3 2017, closing a stake of 9,376 shares — an estimated $470K sold.

Salient Capital Advisors first reported a position in ORCL in Q2 2013 and held it in 17 quarters. The position peaked at $1.45M in Q1 2017. 1,641 funds tracked by Wall St. Rank hold ORCL as of Q3 2017.

  • Salient Capital Advisors reported no remaining Oracle position as of Q3 2017 after selling out during the quarter.
  • Salient Capital Advisors sold 9,376 Oracle shares in Q3 2017, an estimated $470K.
  • Salient Capital Advisors first reported a position in Oracle in Q2 2013 and held it in 17 quarters.
  • Salient Capital Advisors's Oracle position peaked at $1.45M in Q1 2017.
  • 1,641 funds tracked by Wall St. Rank held Oracle as of Q3 2017.

Based on Salient Capital Advisors's 13F filing for Q3 2017, filed 6 Nov 2017.